In the final act of Donald Trump‘s presidency, Yale SOM's Jeffrey Sonnenfeld sees echoes of “monarchical” CEOs who purge truth-tellers and surround themselves with sycophants—and invariably make an involuntary exit from the C-suite.
In a hastily assembled call on November 6, corporate leaders agreed on the importance of smooth transition process and encouraged GOP leaders to endorse the integrity of the election.
As the U.S. approaches a divisive election, writes Yale SOM leadership expert Jeffrey Sonnenfeld, business leaders are calling for patience while ballots are counted and a peaceful transfer of power.
Yale SOM leadership expert Jeffrey Sonnenfeld, who studied a previous wave of diversity initiatives, describes how such well-intentioned initiatives can go awry—and how to get them back on track.
In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
Some have defended cutbacks to the United States Postal Service, weeks ahead of the election, by citing the USPS’s financial struggles. But the postal service was created to provide a public service, writes Yale SOM’s Jeffrey Sonnenfeld, not to turn a profit.
With the Democratic National Convention taking place online, Prof. Jeffrey Sonnenfeld reflects on other conventions Americans have abandoned, and the traditions we’ve let go of, during this tumultuous time.
Yale SOM’s Jeffrey Sonnenfeld reflects on the lessons he learned from the civil rights pioneer and congressman John Lewis about voice, courage, integrity—and the dangers of being too patient.
The Trump administration is reportedly planning to limit immigration for skilled workers in order to boost employment for domestic workers. Yale SOM’s Jeffrey Sonnenfeld writes that such a move would stifle innovation and even endanger Americans’ health.
In a Fortune commentary, Dr. Michael Apkon ’02, president and CEO of Tufts Medical Center, and Yale SOM’s Dr. Howard Forman and Jeffrey Sonnenfeld write that such an approach would be dangerous and ineffective.